Methyl (1R,4S)-4-(tert-Butoxycarbonylamino)cyclopent-2-ene-1-carboxylate, 97%, 1g

Methyl 2-(pyrrolidin-2-yl)benzoate hydrochloride, 97.0%, 250mg

GC capillary column ROTI®Cap-FFAP, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

N-(2,6-Dimethylphenyl)piperidine-2-carboxamide, 95.0%, 100g

2,6-Bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine, 98% 99%ee, 100mg

1,3,3-Trimethyl-6'-(piperidin-1-yl)spiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 97%, 100mg

5-Chloromethyl-3-m-tolyl-[1,2,4]oxadiazole, 95.0%, 5g

Oxazole, 2,2'-cyclohexylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-,(4S,4'S)-, 97%, 1g

4-Acetyl-2-methoxybenzoic acid, 95%, 100mg

3-BROMO-2,7-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

4-Fluoro-3-nitrobenzaldehyde, 97.00%, 500g

Dimethyl 2-(2-methoxyphenoxy)malonate, 95.0%, 500g

(R)-1-(3-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride, 97.0%, 250mg